Smart Glasses, such as Google's glass headset, promise to change the way we interact with technology. How could this change healthcare you might ask, it seems the possibilities are endless. Read more here and find out what Dr Christopher Kaeding, a surgeon at the Ohio State University Wexner Medical […]
What Is The Future Of Value-Based Pricing With ISPOR?
Value-based pricing for pharmaceuticals has been given an implementation deadline of January 1, 2014, but as the this date grows nearer, less and less has been said about it. Many are wondering if VBP will be introduced at all in 2014, and if so, in what form. Full article available here. (Source: […]
Health Insurance: A Gamble That Goes Both Ways?
Last minute changes to the reform law could expose insurance companies to higher risk. To the insurers, deadline extensions mean a loss of premiums from healthy consumers. How will these changes affect the ratio of healthy and sick consumers? How will insurance companies bottom lines be affected? […]
Brand Planning – Who’s On Your Team?
In this article, Jan Steele PhD, operations director at Lucid, discusses the idea of running a parallel planning process that will, in the long run, save time. How would this be set up? Who should be included? What are the benifits? Read her full article here and find out. (Source: PMLiVE, […]
Is A Lack Of Transparency Weakening Evidence-Based Medicine?
A recent study found only half of all drug studies recorded in a large Web-based, federal registry, ClinicalTrials.gov had been published in a journal. Of these published trials, most were not in a timely manner, and many contained only selective information, leaving out such things as […]
Should NICE Lower Cost-Per-QALY Threshold?
The OHE recently published an Occasional Paper by Barnsley et al that counters the recently-published recommendation by Claxton et al that NICE should lower its cost-per-QALY threshold from the current £20,000–£30,000 official range to £12,936. Learn more about the difficulties the […]
Is Public Opinion About The Affordable Care Act Changing?
So, we've all heard about the web site glitches and stories about individuals being dropped from their insurance plans; things don't seem to be moving quite as smoothly as some had hoped! How are these "disruptions" affecting the public's view on the law? Read here about the results from […]
Have You Checked Out The ISPOR Distance Learning Program?
Now available for purchase through the ISPOR Distance Learning Program (iDLP), Modeling Health Care Costs-Characteristics of Health Care Costs. This module provides a general view of simple regression analysis with an explanation of why a standard simple approach fails in the estimation of medical […]
How Is Pharma Responding To The Informed Patient Movement?
This FirstWord Report explores the unknowns of patient empowerment and provides a critical overview that aims to establish a broad consensus, best practices and insight into how to integrate patient-centricity into the pharma business model. Purchase required. (Source: FirstWord, 7/2013). […]
The Very Active Oncology Pipeline
In the past 3 years, approximately one-third of drugs the FDA has approved have been intended to treat cancer. The trend is expected to continue for the foreseeable future, as oncology is the leading category of pharmaceuticals in the pipeline. Burt Zweigenhaft, chief executive officer of Onco360, […]
Market Access and Reimbursement Information in Specialty Drug Prescription Decisions has Many Challeges
Jayne Hornung, RPh, vice president/pharmacy and medical data for Managed Markets Insight & Technology noted at the NASP meeting that "It is a broken system". Dr. Hornung noted the many challenges that exist throughtout the healthcare system during her session. Read more about research Managed […]
Michael J. Fox to Keynote Specialty Pharmacy Summit
Armada Health Care has announced that Michael J. Fox will keynote the 10th Annual Specialty Pharmacy Summit & Expo. Best known for his acting, Fox is now an author, speaker and spokesperson for The Michael J. Fox Foundation for Parkinson's Research. The Summit takes place at the Wynn Hotel in […]
NICE Lower Threshold Research – What Does Ulf Stagginus Have To Say About?
Ulf tells it like it is here! […]
Ebook: Top Market Access Services Required By Pharma
Download available here. (Source: totalbiopharma, 2013). […]
Fortune 500 Insurance Co CEOs – How Much $$ Is Too Much?
Be sure to click on the CEOs of the 8 largest insurance companies in this article. Find out where they are taking their company, what their stance on health reform is, and how much money they recieved in the past year! Did these eight health insurance leaders deserve their paychecks? Do some deserve […]
Is The ACO Trend Fading?
Why has ACO growth slowed? Could we see a come back? Read more. (NPC, 2013). […]
What Do Childhood Obesity And Immunizations Have In Common?
Read more about these trends here. (Source: NPC, 2013). […]
How Can Rare Disease Treatments Be Effectively Assessed?
Read full article here for the results. (Source: OHE, 12/5/13). […]
Will Genzyme’s MS Drug Get NICE Approval?
More information here. (Source: PMLiVE, 12/6/13). […]
Who Is Mike Herdman?
Get to know Mike Herdman and the new position at OHE. (Source: OHE, 11/25/13). […]
Comparative Effectiveness Research-Are Decision Makers Using It?
The Agency for Healthcare Research and Quality's (AHRQ) CER reviews are well known, but few participants in recent focus groups had actually used them in the P&T process. Why are decision makers not using CER reviews, and what needs to be done to increase the use of the AHRQ CER reviews in […]
Biopharma – Need A Little Revenue Management Intelligence?
Failing to control your pricing on a global level can translate into poor relationships with governments and margin loss amounting to tens of millions of dollars as a result of uncoordinated price changes or product launches. What if you could eliminate the risk of government price reporting errors, […]
Have You Heard About PatientsLikeMe?
PatientsLikeMe is an online patient network that has removed traditional barriers between researchers and patients. Partnering with companies such as Sanofi and inVentiv, PatientsLikeMe is able to provide its 200,000 members with a real-time research platform, streamlining research, accelerating […]
Pharma – Still Needing To Mobilize? Don’t Miss This Webinar Dec. 17!
On December 17, Manhattan Research Vice President of Research, Monique Levy, is hosting an exclusive webinar for clients of the ePharma Competitive Analysis Series. Levy will review key benchmarks, trends and best practices of the consumer-facing pharma website and branded online support program […]
Are Companies Leaving Money On The Table When Seeking Reimbursement?
This article takes a look at a study involving the data on reimbursement submissions, decisions, and re-submissions, that was recently presented at the ISPOR European Congress in Dublin. What they found was really quite interesting-62% of the HTAs that were rejected on the first submission never […]
What Is The Relationship Between Patient Satisfaction And Outcomes?
After taking a look at various surveys, intitial conclusions seem to change when more probing questions are asked. What defines the quality of health care? Is it a clean lobby? Is it outcomes based? Results from these studies suggest it's the result of a cooperative staff culture, involvement of the […]
Global Pricing – How Do We Successfully Manage It?
It's not a small undertaking that's for sure, but to successfully manage global pricing, the culture of the pricing team requires formidable change. Not only systems, but people, processes, and plans need to evolve. Pharma manufacturers must create a global pricing strategy that anticipates […]
AMCP Downloads – Handouts & Audio Recordings!
Were you in San Antonio for the AMCP Nexus 2013? If so, you can use your registration ID to access and download the handouts and audio recordings for ALL the Education Tracks! […]
AMCP Nexus 2013 – Exclusive Bonus Sessions!
Did you attend AMCP Nexus 2013? If so, you have access to these exclusive bonus sessions! -Federal & State Legislative and Regulatory Update -Examine the Impact of Accountable Care Organizations (ACO) on the Specialty Pharmacy Channel […]
AMCP Nexus 2013 – Were You There?
Nearly 1800 AMCP members attended the inaugural AMCP Nexus 2013- sharing in four days of learning, networking and fun as we gathered in San Antonio, Texas. Re-experience the magic of AMCP Nexus 2013-View the Nexus PowerPoint and photo gallery and get a taste of this great conference! […]
